Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Assets ratio is N/A as of 2026-10-06T18:02:25.035Z.
Calculation as of: 2026-10-06T18:02:25.035Z.
Quote observation: 2026-10-06T17:46:08.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: bcc3f1894ec499320e43c54a24f2662d6ad9e54feca4b92c79248349e67b8166
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2025-03-17.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
N/A
EV/ASSETS RATIO AVG TTM
102.55x
EV/ASSETS RATIO AVG 3Y
102.24x
EV/ASSETS RATIO AVG 5Y
N/A
EV/ASSETS RATIO AVG 10Y
N/A
EV/ASSETS RATIO AVG 15Y
N/A
EV/ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$4.12M
EV/Assets Ratio
0.76x
TTM Avg
0.22x
3Y Avg
0.60x
5Y Avg
1.28x
Market Cap
$4.02M
EV/Assets Ratio
N/A
TTM Avg
0.24x
3Y Avg
0.19x
5Y Avg
1.15x
Market Cap
$4.20M
EV/Assets Ratio
1.94x
TTM Avg
1.04x
3Y Avg
0.75x
5Y Avg
0.97x
Market Cap
$4.30M
EV/Assets Ratio
0.05x
TTM Avg
16.29x
3Y Avg
16.29x
5Y Avg
16.29x
Market Cap
$4.34M
EV/Assets Ratio
0.56x
TTM Avg
0.54x
3Y Avg
0.95x
5Y Avg
1.27x
Market Cap
$4.51M
EV/Assets Ratio
0.02x
TTM Avg
0.14x
3Y Avg
0.36x
5Y Avg
29.27x
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GRI Bio, Inc. (GRI) | $4.09M | N/A | 102.55x | 102.24x | N/A |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $4.12M | 0.76x | 0.22x | 0.60x | 1.28x |
| Aptevo Therapeutics Inc. (APVO)vs › | $4.02M | N/A | 0.24x | 0.19x | 1.15x |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.20M | 1.94x | 1.04x | 0.75x | 0.97x |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.30M | 0.05x | 16.29x | 16.29x | 16.29x |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.34M | 0.56x | 0.54x | 0.95x | 1.27x |
| Evogene Ltd. (EVGN)vs › | $3.68M | N/A | 0.30x | 0.38x | 3.01x |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.51M | 0.02x | 0.14x | 0.36x | 29.27x |
| Eocene Ltd. (EOCN)vs › | $3.64M | N/A | N/A | N/A | N/A |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.63M | N/A | 0.54x | 6.84x | 13.23x |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/ASSETS RATIO |
|---|---|
| 2025-03-17 | 140.90x |
| 2025-03-14 | 150.23x |
| 2025-03-13 | 150.48x |
| 2025-03-12 | 149.22x |
| 2025-03-11 | 154.26x |
| 2025-03-10 | 162.84x |
| 2025-03-07 | 164.61x |
| 2025-03-06 | 170.15x |
| 2025-03-05 | 173.94x |
| 2025-03-04 | 176.46x |
| 2025-03-03 | 191.84x |
| 2025-02-28 | 198.91x |
| 2025-02-27 | 200.67x |
| 2025-02-26 | 205.97x |
| 2025-02-25 | 183.27x |
| 2025-02-24 | 175.45x |
| 2025-02-21 | 177.22x |
| 2025-02-20 | 185.79x |
| 2025-02-19 | 226.40x |
| 2025-02-18 | 236.99x |
| 2025-02-14 | 234.97x |
| 2025-02-13 | 230.69x |
| 2025-02-12 | 234.97x |
| 2025-02-11 | 211.52x |
| 2025-02-10 | 205.46x |
| 2025-02-07 | 204.46x |
| 2025-02-06 | 211.77x |
| 2025-02-05 | 226.40x |
| 2025-02-04 | 227.91x |
| 2025-02-03 | 269.27x |
| 2025-01-31 | 270.03x |
| 2025-01-30 | 280.62x |
| 2025-01-29 | 269.27x |
| 2025-01-28 | 269.27x |
| 2025-01-27 | 272.80x |
| 2025-01-24 | 262.72x |
| 2025-01-23 | 293.23x |
| 2025-01-22 | 287.18x |
| 2025-01-21 | 297.27x |
| 2025-01-17 | 308.11x |
| 2025-01-16 | 301.56x |
| 2025-01-15 | 313.66x |
| 2025-01-14 | 320.22x |
| 2025-01-13 | 312.15x |
| 2025-01-10 | 326.02x |
| 2025-01-08 | 314.17x |
| 2025-01-07 | 353.51x |
| 2025-01-06 | 355.78x |
| 2025-01-03 | 388.07x |
| 2025-01-02 | 363.60x |
| 2024-12-31 | 354.27x |
| 2024-12-30 | 341.41x |
| 2024-12-27 | 332.33x |
| 2024-12-26 | 335.61x |
| 2024-12-24 | 329.30x |
| 2024-12-23 | 322.24x |
| 2024-12-20 | 316.44x |
| 2024-12-19 | 329.30x |
| 2024-12-18 | 319.97x |
| 2024-12-17 | 333.59x |
| 2024-12-13 | 0.00x |
| 2024-12-12 | 0.05x |
| 2024-12-11 | 0.18x |
| 2024-12-10 | 0.14x |
| 2024-12-09 | 0.08x |
| 2024-11-14 | 0.18x |
| 2024-11-13 | 0.09x |
| 2024-11-12 | 0.06x |
| 2024-11-11 | 0.04x |
| 2024-11-08 | 0.09x |
| 2024-11-07 | 0.09x |
| 2024-11-06 | 0.17x |
| 2024-11-05 | 0.21x |
| 2024-11-04 | 0.27x |
| 2024-11-01 | 0.33x |
| 2024-10-31 | 0.09x |
| 2024-10-30 | 0.03x |
| 2024-10-24 | 0.03x |
| 2024-10-23 | 0.01x |
| 2024-10-22 | 0.19x |
| 2024-10-21 | 0.58x |
| 2024-06-25 | 0.24x |
| 2024-06-24 | 0.16x |
| 2024-06-21 | 0.15x |
| 2024-06-20 | 0.11x |
| 2024-06-18 | 0.23x |
| 2024-06-17 | 0.21x |
| 2024-06-14 | 0.24x |
| 2024-06-13 | 0.35x |
| 2024-06-12 | 0.33x |
| 2024-06-11 | 0.37x |
| 2024-06-10 | 0.38x |
| 2024-06-07 | 0.43x |
| 2024-06-06 | 0.44x |
| 2024-06-05 | 0.46x |
| 2024-06-04 | 0.47x |
| 2024-06-03 | 0.47x |
| 2024-05-31 | 0.51x |
| 2024-05-30 | 0.62x |
| 2024-05-29 | 0.60x |
| 2024-05-28 | 0.56x |
| 2024-05-24 | 0.57x |
| 2024-05-23 | 0.93x |
| 2024-05-22 | 1.08x |
| 2024-05-21 | 0.93x |
| 2024-05-20 | 0.99x |
| 2024-05-17 | 0.95x |
| 2024-05-16 | 0.92x |
| 2024-05-15 | 0.88x |
| 2024-05-14 | 0.90x |
| 2024-05-13 | 0.91x |
| 2024-05-10 | 0.92x |
| 2024-05-09 | 0.91x |
| 2024-05-08 | 0.84x |
| 2024-05-07 | 0.87x |
| 2024-05-06 | 0.94x |
| 2024-05-03 | 0.92x |
| 2024-05-02 | 0.99x |
| 2024-05-01 | 0.97x |
| 2024-04-30 | 0.98x |
| 2024-04-29 | 0.99x |
| 2024-04-26 | 0.99x |
| 2024-04-25 | 0.99x |
| 2024-04-24 | 1.02x |
| 2024-04-23 | 1.05x |
| 2024-04-22 | 1.10x |
| 2024-04-19 | 1.35x |
| 2024-04-18 | 1.31x |
| 2024-04-17 | 1.29x |
| 2024-04-16 | 1.34x |
| 2024-04-15 | 1.36x |
| 2024-04-12 | 1.29x |
| 2024-04-11 | 1.29x |
| 2024-04-10 | 1.35x |
| 2024-04-09 | 1.47x |
| 2024-04-08 | 1.42x |
| 2024-04-05 | 1.32x |
| 2024-04-04 | 1.37x |
| 2024-04-03 | 1.35x |
| 2024-04-02 | 1.45x |
| 2024-04-01 | 2.18x |
| 2024-03-28 | 2.22x |
| 2024-03-27 | 2.27x |
| 2024-03-26 | 2.19x |
| 2024-03-25 | 2.27x |
| 2024-03-22 | 2.30x |
| 2024-03-21 | 2.31x |
| 2024-03-20 | 2.35x |
| 2024-03-19 | 2.20x |
| 2024-03-18 | 2.20x |
| 2024-03-15 | 0.97x |
| 2024-03-14 | 0.98x |
| 2024-03-13 | 1.05x |
| 2024-03-12 | 1.14x |
| 2024-03-11 | 1.14x |
| 2024-03-08 | 1.21x |
| 2024-03-07 | 1.05x |
| 2024-03-06 | 1.07x |
| 2024-03-05 | 1.06x |
| 2024-03-04 | 1.12x |
| 2024-03-01 | 1.08x |
| 2024-02-29 | 1.04x |
| 2024-02-28 | 1.11x |
| 2024-02-27 | 1.06x |
| 2024-02-26 | 1.22x |
| 2024-02-23 | 1.20x |
| 2024-02-22 | 1.14x |
| 2024-02-21 | 1.40x |
| 2024-02-20 | 1.42x |
| 2024-02-16 | 1.58x |
| 2024-02-15 | 1.63x |
| 2024-02-14 | 1.72x |
| 2024-02-13 | 1.81x |
| 2024-02-12 | 1.97x |
| 2024-02-09 | 2.26x |
| 2024-02-08 | 2.06x |
| 2024-02-07 | 1.94x |
| 2024-02-06 | 2.22x |
| 2024-02-05 | 2.22x |
| 2024-02-02 | 2.49x |
| 2024-02-01 | 3.65x |
| 2024-01-31 | 2.90x |
| 2024-01-30 | 5.74x |
| 2024-01-29 | 5.30x |
| 2024-01-26 | 3.92x |
| 2024-01-25 | 3.67x |
| 2024-01-24 | 3.37x |
| 2024-01-23 | 3.63x |
| 2024-01-22 | 3.83x |
| 2024-01-19 | 3.55x |
| 2024-01-18 | 3.77x |
| 2024-01-17 | 3.83x |
| 2024-01-16 | 3.85x |
| 2024-01-12 | 4.23x |
| 2024-01-11 | 4.33x |
| 2024-01-10 | 4.39x |
| 2024-01-09 | 4.80x |
| 2024-01-08 | 4.41x |
| 2024-01-05 | 4.41x |
| 2024-01-04 | 4.39x |
| 2024-01-03 | 4.47x |
| 2024-01-02 | 4.87x |
| 2023-12-29 | 5.34x |
| 2023-12-28 | 5.41x |
| 2023-12-27 | 4.70x |
| 2023-12-26 | 4.59x |
| 2023-12-22 | 4.47x |
| 2023-12-21 | 5.12x |
| 2023-12-20 | 5.66x |
| 2023-12-19 | 5.77x |
| 2023-12-18 | 6.16x |
| 2023-12-15 | 6.21x |
| 2023-12-14 | 6.05x |
| 2023-12-13 | 5.77x |
| 2023-12-12 | 5.51x |
| 2023-12-11 | 6.38x |
| 2023-12-08 | 7.18x |
| 2023-12-07 | 8.06x |
| 2023-12-06 | 7.45x |
| 2023-12-05 | 7.97x |
| 2023-12-04 | 10.95x |
| 2023-12-01 | 11.38x |
| 2023-11-30 | 8.94x |
| 2023-11-29 | 8.90x |
| 2023-11-28 | 7.49x |
| 2023-11-27 | 9.56x |
| 2023-11-24 | 11.16x |
| 2023-11-22 | 12.13x |
| 2023-11-21 | 15.13x |
| 2023-11-20 | 15.62x |
| 2023-11-17 | 16.51x |
| 2023-11-16 | 16.16x |
| 2023-11-15 | 16.89x |
| 2023-11-14 | 18.12x |
| 2023-11-13 | 18.00x |
| 2023-11-10 | 19.28x |
| 2023-11-09 | 19.44x |
| 2023-11-08 | 18.72x |
| 2023-11-07 | 18.64x |
| 2023-11-06 | 18.48x |
| 2023-11-03 | 18.48x |
| 2023-11-02 | 18.64x |
| 2023-11-01 | 18.32x |
| 2023-10-31 | 18.64x |
| 2023-10-30 | 17.69x |
| 2023-10-27 | 17.37x |
| 2023-10-26 | 17.21x |
| 2023-10-25 | 16.33x |
| 2023-10-24 | 16.57x |
| 2023-10-23 | 16.81x |
| 2023-10-20 | 17.53x |
| 2023-10-19 | 18.32x |
| 2023-10-18 | 18.48x |
| 2023-10-17 | 19.60x |
| 2023-10-16 | 22.94x |
| 2023-10-13 | 22.94x |
| 2023-10-12 | 23.10x |
| 2023-10-11 | 23.10x |
| 2023-10-10 | 23.34x |
| 2023-10-09 | 24.06x |
Showing the most recent 260 of 928 data points. The chart above shows the full history.
